Sanofi's quadrivalent flu shot safe in kids; No increased risk to babies for H1N1 vax in pregnancy;

> Sanofi Pasteur's quadrivalent version of its Fluzone flu vaccine was safe and effective in a Phase III trial in children aged 6 months to 8 years. Press release

> There is no evidence of increases in fetal death in pregnant women receiving a pandemic A/H1N1 influenza vaccine during pregnancy. Abstract

> Inovio's SynCon vaccine for cervical dysplasias and cancers has been granted a U.S. patent. Article

> Profectus has received an NIAID grant to develop a vaccine against Ebola and Marburg viruses. Press release

> Galena Biopharma ($GALE) has received a notice of allowance for a U.S. patent for folate binding protein vaccines. Press release

And Finally… Allergy Therapeutics, which specializes in allergy vaccines, has appointed Dr. Thomas Lander as a non-executive director. Press release

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.